Pharmacoeconomic study of the degarelix drug use for treatment of hormone-dependent prostate cancer compared  to gonadotropin-releasing hormone analogs

A. G. Tolkushin; N. L. Pogudina

For citations:

Tolkushin A.G., Pogudina N.L. Pharmacoeconomic study of the degarelix drug use for treatment of hormone-dependent prostate cancer compared to gonadotropin-releasing hormone analogs. Cancer Urology. 2018;14(1):126-135. (In Russ.) https://doi.org/10.17650/1726-9776-2018-14-1-126-135

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1726-9776 (Print)
ISSN 1996-1812 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Cancer Urology

For citations:

Cookies policy